Oct 22 (Reuters) - SV Partner CREDITORS RESOLVED THAT VIVID TECHNOLOGY WILL BE WOUND UP; JOINT AND SEVERAL LIQUIDATORS APPOINTED
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status